Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome

Nuccia Morici(Don Carlo Gnocchi Foundation), Stefano Savonitto(Alessandro Manzoni Hospital), Stefano De Servi(University of Pavia), Roberto Antonicelli(Istituto Nazionale di Riposo e Cura per Anziani), Ernesto Murena(Ospedale Santa Maria), Leonardo Bolognese(Azienda Usl 8 Arezzo), Anna Toso(Azienda Usl Toscana Centro), Claudio Cavallini, Fabio Angeli(University of Insubria), Anna Sonia Petronio(University of Pisa), Federico Piscione(University of Liège)
European Heart Journal Acute Cardiovascular Care
October 27, 2014
10.1177/2048872614557221
Cited by 18

Related Papers

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
|The Lancet|2007|1.4k
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
|European Journal of Internal Medicine|2020|1.3k
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
|New England Journal of Medicine|2013|651